American College of Clinical Pharmacy
      Search      Cart

Immunology/Transplant PRN Focus Session -- Path of Least Resistance: Narrowing and Minimizing Anti-Infectives in Solid Organ Transplantation

Saturday, October 26, 2019 from 3:30 PM to 5:00 PM EDT at 2nd Floor: Sutton Center/South

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-19-176-L01-P
Activity Type: A Knowledge-Based Activity

  • Aileen Chi, Pharm.D.Moderator: Aileen Chi, Pharm.D.

Management of the Post-operative Cardiothoracic Transplant Recipient with Existing Infections Prior to Transplant
3:30 PM

  • Tamara E. Claridge, Pharm.D., BCPSSpeaker: Tamara E. Claridge, Pharm.D., BCPS
    Clinical Pharmacy Specialist Lung Transplant, Hospital of the University of Pennsylvania, Philadelphia, PA
      View Biography

Learning Objectives
1. Describe the prevalence of ventricular assist device infections and risk factors for persistence of these infections after orthotopic heart transplantation.
2. Discuss the prevalence and risk factors for a recurrent infection post-lung transplant in patients with pre-existing native lung infections or colonization.
3. Evaluate the appropriate choice and duration of surgical infection prophylaxis in cardiothoracic patients with pre-existing infections prior to transplant.
4. Apply antimicrobial stewardship strategies to optimize antimicrobial use in cardiothoracic recipients with preexisting infections prior to transplant.
Asymptomatic Bacteriuria in Solid Organ Transplant Recipients
4:00 PM

  • Lyndsey J. Bowman, Pharm.D.Speaker: Lyndsey J. Bowman, Pharm.D.
    Kidney and Pancreas Transplant Pharmacotherapy Specialist; Co-Residency Program Director, PGY2 Solid Organ Transplant Resident Program; Clinical Coordinator, Solid Organ Transplant Pharmacists; Tampa General Hospital, Tampa, Florida
      View Biography

Learning Objectives
1. Discuss the prevalence and risk factors of asymptomatic bacteriuria in post-kidney transplant recipients.
2. Review the risks of overtreatment of asymptomatic bacteriuria and development of antimicrobial resistance post-transplant.
3. Evaluate management of asymptomatic bacteriuria post-transplant in solid organ transplant recipients.
4. Discuss the role of antimicrobial stewardship in management of asymptomatic bacteriuria post-transplant.
Antifungal Stewardship in Solid Organ Transplant
4:30 PM

  • Jason C. Gallagher, Pharm.D., FCCP, BCPSSpeaker: Jason C. Gallagher, Pharm.D., FCCP, BCPS
    Clinical Professor, Temple University School of Pharmacy, Philadelphia, Pennsylvania
      View Biography

Learning Objectives
1. Discuss the risks and prevalence of fungal infections in the solid organ transplant population.
2. Describe how fungal infections affect transplant outcomes.
3. Review current antifungal therapies and mechanisms of fungal resistance.
4. Evaluate the need for antifungal stewardship and illustrate implications of an antifungal stewardship program.